|
|
In the cross-sectional analysis,significant associations were observed between HIV-1-associated HAs and(1)anxiety and depression,and(2)a history of drug use,psychiatric disease,and non-HIV-1 neurologic disease.No significant differences in laboratory values were found between subjects with HIV-1-associated HA compared with those without HA.When HIV+subjects were followed longitudinally,onset of new HIV-1-associated systemic or neurologic disease over 1 year was not predicted by the presence of an HIV-1-associated HA at baseline.Headaches are common in HIV+persons at all states of disease.Presence of HIV-1-associated HAs at baseline were not associated with neurologic disease progression over 1 year follow-up in our sample. |
|